Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Total 13F shares
-
92,595,818
-
Share change
-
+39,106
-
Total reported value
-
$76,020,982,589
-
Put/Call ratio
-
110%
-
Price per share
-
$821.67
-
Number of holders
-
1,182
-
Value change
-
+$89,011,870
-
Number of buys
-
550
-
Number of sells
-
498
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2023
As of 31 Mar 2023,
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) was held by
1,182 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,595,818 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, Capital World Investors, STATE STREET CORP, Dodge & Cox, GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, and Capital International Investors.
This page lists
1,182
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.